Jinling Pharmaceutical Co Ltd
SZSE:000919
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jinling Pharmaceutical Co Ltd
SZSE:000919
|
CN |
|
N
|
Nha Be Water Supply JSC
VN:NBW
|
VN |
|
SUTL Enterprise Ltd
SGX:BHU
|
SG |
|
Mandarin Oriental International Ltd
SGX:M04
|
HK |
|
E
|
Enish Inc
TSE:3667
|
JP |
|
M
|
Moneta Money Bank as
PSE:MONET
|
CZ |
|
Banca Mediolanum SpA
MIL:BMED
|
IT |
|
S
|
SNTEnergy Co Ltd
KRX:100840
|
KR |
|
L E Lundbergforetagen AB (publ)
STO:LUND B
|
SE |
|
A
|
Advance Synergy Bhd
KLSE:ASB
|
MY |
|
Wacoal Holdings Corp
TSE:3591
|
JP |
|
DRS Dilip Roadlines Ltd
NSE:DRSDILIP
|
IN |
|
Niitaka Co Ltd
TSE:4465
|
JP |
|
P
|
Pudjiadi And Sons Tbk PT
IDX:PNSE
|
ID |
|
Denison Mines Corp
TSX:DML
|
CA |
|
D-Link Corp
TWSE:2332
|
TW |
|
Synlait Milk Ltd
NZX:SML
|
NZ |
|
T
|
Tianjin Binhai Energy & Development Co Ltd
SZSE:000695
|
CN |
|
C
|
Caswell Inc
TWSE:6416
|
TW |
|
A
|
ASM Pacific Technology Ltd
HKEX:522
|
HK |
|
GDS Global Ltd
SGX:5VP
|
SG |
|
P
|
Proactis SA
PAR:PROAC
|
FR |
|
E
|
Echo Investment SA
WSE:ECH
|
PL |
|
B
|
Bodal Chemicals Ltd
NSE:BODALCHEM
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jinling Pharmaceutical Co Ltd's stock price target?
Not Available
Jinling Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Jinling Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 7 years is 1%.
What is Jinling Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
30%
For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's operating income is -14%. The projected CAGR for the next 7 years is 30%.
What is Jinling Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
27%
For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's net income is -10%. The projected CAGR for the next 7 years is 27%.
